Oncohematology

Онкогематология

1818-83462413-4023

Publishing House ABV Press

212

10.17650/1818-8346-2016-11-4-18-24

HEMATOLOGIC MALIGNANCIES: DIAGNOSIS, TREATMENT, SUPPORTIVE CARE

ГЕМОБЛАСТОЗЫ: ДИАГНОСТИКА, ЛЕЧЕНИЕ, СОПРОВОДИТЕЛЬНАЯ ТЕРАПИЯ

PROGNOSTIC SIGNIFICANCE OF POSITRON EMISSION TOMOGRAPHY IN AUTOLOGOUS STEM CELL TRANSPLANTATION FOR NON-HODGKIN’S LYMPHOMA

РОЛЬ ПОЗИТРОННО-ЭМИССИОННОЙ ТОМОГРАФИИ В ПРОГНОЗИРОВАНИИ РЕЗУЛЬТАТОВ АУТОЛОГИЧНОЙ ТРАНСПЛАНТАЦИИ СТВОЛОВЫХ КЛЕТОК У ПАЦИЕНТОВ С НЕХОДЖКИНСКИМИ ЛИМФОМАМИ

Potapenko

V. G.

Потапенко

В. Г.

Russian Federation

6–8 L’va Tolstogo St., Saint Petersburg 197022, Russia; 3 Dinamo Prospekt, Saint Petersburg 197110, Russia

197022 Санкт-Петербург, ул. Льва Толстого, 6–8; 197110 Санкт-Петербург, проспект Динамо, 3; potapenko.vsevolod@mail.ru

potapenko.vsevolod@mail.ru

Mikhaylova

N. B.

Михайлова

Н. Б.

Russian Federation

6–8 L’va Tolstogo St., Saint Petersburg 197022, Russia

197022 Санкт-Петербург, ул. Льва Толстого, 6–8

Smirnov

B. I.

Смирнов

Б. И.

Russian Federation

5 Professora Popova St., Saint Petersburg 197376, Russia

197376 Санкт-Петербург, ул. Профессора Попова, 5

Skorokhod

I. A.

Скороход

И. А.

Russian Federation

3 Dinamo Prospekt, Saint Petersburg 197110, Russia

197110 Санкт-Петербург, проспект Динамо, 3

Chaginskaya

D. A.

Чагинская

Д. А.

Russian Federation

3 Dinamo Prospekt, Saint Petersburg 197110, Russia

197110 Санкт-Петербург, проспект Динамо, 3

Ryabchikova

V. V.

Рябчикова

В. В.

Russian Federation

3 Dinamo Prospekt, Saint Petersburg 197110, Russia

197110 Санкт-Петербург, проспект Динамо, 3

Samorodova

I. А.

Самородова

И. А.

Russian Federation

3 Dinamo Prospekt, Saint Petersburg 197110, Russia

197110 Санкт-Петербург, проспект Динамо, 3

Podol’tseva

E. I.

Подольцева

Э. И.

Russian Federation

3 Dinamo Prospekt, Saint Petersburg 197110, Russia

197110 Санкт-Петербург, проспект Динамо, 3

Ipatov

V. V.

Ипатов

В. В.

Russian Federation

6 Akademika Lebedeva St., Saint Petersburg 194044, Russia

194044 Санкт-Петербург, ул. Академика Лебедева, 6

Boykov

I. V.

Бойков

И. В.

Russian Federation

6 Akademika Lebedeva St., Saint Petersburg 194044, Russia

194044 Санкт-Петербург, ул. Академика Лебедева, 6

Semelev

V. N.

Семелев

В. Н.

Russian Federation

6 Akademika Lebedeva St., Saint Petersburg 194044, Russia

194044 Санкт-Петербург, ул. Академика Лебедева, 6

Gornostaev

D. A.

Горностаев

Д. А.

Russian Federation

6 Akademika Lebedeva St., Saint Petersburg 194044, Russia

194044 Санкт-Петербург, ул. Академика Лебедева, 6

Potapenko

T. G.

Потапенко

Т. Г.

Russian Federation

7–9 Universitetskaya Naberezhnaya, Saint Petersburg 199034, Russia

199034 Санкт-Петербург, Университетская набережная, 7–9

Kulibaba

T. G.

Кулибаба

Т. Г.

Russian Federation

7–9 Universitetskaya Naberezhnaya, Saint Petersburg 199034, Russia

199034 Санкт-Петербург, Университетская набережная, 7–9

Medvedeva

N. V.

Медведева

Н. В.

Russian Federation

3 Dinamo Prospekt, Saint Petersburg 197110, Russia

197110 Санкт-Петербург, проспект Динамо, 3

Afanas’ev

B. V.

Афанасьев

Б. В.

Russian Federation

6–8 L’va Tolstogo St., Saint Petersburg 197022, Russia

197022 Санкт-Петербург, ул. Льва Толстого, 6–8

I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of RussiaПервый Санкт-Петербургский государственный медицинский университет имени И.П. Павлова

Saint Petersburg City Oncohematological Center based on City Clinical Hospital No 31Санкт-Петербургский городской центр онкогематологии на базе СПб ГБУЗ «Городская клиническая больница № 31»

V.I. Ul’yanov (Lenin) Saint Petersburg State Electrotechnical University “LETI”Санкт-Петербургский государственный электротехнический университет «ЛЭТИ» имени В.И. Ульянова (Ленина)

S.M. Kirov Military Medical AcademyВоенно-медицинская академия имени С.М. Кирова

Saint Petersburg State UniversityСанкт-Петербургский государственный университет

03122016

114

18240301201703012017

2016

https://oncohematology.abvpress.ru/ongm/article/view/212

positron emission tomographylymphomaautologous hematopoietic stem cell transplantationhigh-dose chemotherapyпозитронно-эмиссионная томографиялимфомааутологичная трансплантация гемопоэтических стволовых клетоквысокодозная химиотерапия1.1. Жуков Н.В., Румянцев А.Г., Усс А.Л. и др. Эффективность и безопасность высокодозной химиотерапии с аутологичной трансплантацией гемопоэтических стволовых клеток у больных с неблагоприятным течением лимфомы Ходжкина. Опыт трансплантационных центров России, Украины и республики Беларусь. Вопросы гематологии, онкологии и иммунопатологии в педиатрии 2014;13(1): 22–31. [Zhukov N.V., Rumyantsev A.G., Uss A.L. et al. Efficiency and safety of highdose chemotherapy followed by autologous hematopoietic stem cell transplantation in patients with an unfavorable Hodgkin’s lymphoma. Experience of Russian, Ukrainian and Belarus transplantation centers. Voprosy gematologii, onkologii i immunopatologii v pediatrii = Hematology, Oncology and Immunopathology in Pediatrics 2014;13(1):22–31 (In Russ.)].Жуков Н.В., Румянцев А.Г., Усс А.Л. и др. Эффективность и безопасность высокодозной химиотерапии с аутологичной трансплантацией гемопоэтических стволовых клеток у больных с неблагоприятным течением лимфомы Ходжкина. Опыт трансплантационных центров России, Украины и республики Беларусь. Вопросы гематологии, онкологии и иммунопатологии в педиатрии 2014;13(1): 22–31. [Zhukov N.V., Rumyantsev A.G., Uss A.L. et al. Efficiency and safety of highdose chemotherapy followed by autologous hematopoietic stem cell transplantation in patients with an unfavorable Hodgkin’s lymphoma. Experience of Russian, Ukrainian and Belarus transplantation centers. Voprosy gematologii, onkologii i immunopatologii v pediatrii = Hematology, Oncology and Immunopathology in Pediatrics 2014;13(1):22–31 (In Russ.)].2.2. Федоренко Д.А., Мельниченко В.Я., Ионова Т.И. и др. Клиническая оценка эффективности аутологичной трансплантации кроветворных стволовых клеток при лимфомах. Вестник Национального медико-хирургического центра имени Н.И. Пирогова 2013;8(4):62–5. [Fedorenko D.A., Mel’nichenko V.Ya., Ionova T.I. et al. Clinical evaluation of autologous hematopoietic stem cells transplantation in lymphomas. Vestnik Natsional’nogo mediko-khirurgicheskogo tsentra im. N.I. Pirogova = Bulletin of N.I. Pirogov National Medical and Surgical Center 2013;8(4):62–5. (In Russ.)].Федоренко Д.А., Мельниченко В.Я., Ионова Т.И. и др. Клиническая оценка эффективности аутологичной трансплантации кроветворных стволовых клеток при лимфомах. Вестник Национального медико-хирургического центра имени Н.И. Пирогова 2013;8(4):62–5. [Fedorenko D.A., Mel’nichenko V.Ya., Ionova T.I. et al. Clinical evaluation of autologous hematopoietic stem cells transplantation in lymphomas. Vestnik Natsional’nogo mediko-khirurgicheskogo tsentra im. N.I. Pirogova = Bulletin of N.I. Pirogov National Medical and Surgical Center 2013;8(4):62–5. (In Russ.)].3.3. Barrington S.F., Mikhaeel N.G., Kostakoglu L. et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 2014;32(27):3048–58. DOI: 10.1200/JCO.2013.53.5229. PMID: 25113771.Barrington S.F., Mikhaeel N.G., Kostakoglu L. et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 2014;32(27):3048–58. DOI: 10.1200/JCO.2013.53.5229. PMID: 25113771.4.4. Асланиди И.П., Мухортова О.В., Шурупова И.В. и др. Позитронно-эмиссионная томография: уточнение стадии болезни при злокачественных лимфомах. Клиническая онкогематология 2010;3(2):119–29. [Aslanidi I.P., Mukhortova O.V., Shurupova I.V. et al. Positron emission tomography: staging of malignant lymphomas. Klinicheskaya onkogematologiya = Clinical Oncohematology 2010;3(2):119–29. (In Russ.)].Асланиди И.П., Мухортова О.В., Шурупова И.В. и др. Позитронно-эмиссионная томография: уточнение стадии болезни при злокачественных лимфомах. Клиническая онкогематология 2010;3(2):119–29. [Aslanidi I.P., Mukhortova O.V., Shurupova I.V. et al. Positron emission tomography: staging of malignant lymphomas. Klinicheskaya onkogematologiya = Clinical Oncohematology 2010;3(2):119–29. (In Russ.)].5.5. Сremerius U., Fabry U., Wildberger J.E. et al. Pre-transplant positron emission tomography (PET) using fluorine-18-fluorodeoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin’s lymphoma. Bone Marrow Transplant 2002;30(2):103–11. DOI: 10.1038/sj.bmt.1703607. PMID: 12132049.Сremerius U., Fabry U., Wildberger J.E. et al. Pre-transplant positron emission tomography (PET) using fluorine-18-fluorodeoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin’s lymphoma. Bone Marrow Transplant 2002;30(2):103–11. DOI: 10.1038/sj.bmt.1703607. PMID: 12132049.6.6. Schot B.W., Zijlstra J.M., Sluiter W.J. et al. Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma. Blood 2007;109(2):486–91. DOI: 10.1182/blood-2005-11-006957. PMID: 17003382.Schot B.W., Zijlstra J.M., Sluiter W.J. et al. Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma. Blood 2007;109(2):486–91. DOI: 10.1182/blood-2005-11-006957. PMID: 17003382.7.7. Spaepen K., Stroobants S., Dupont P. et al. Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high- dose chemotherapy and stem cell transplantation. Blood 2003;102(1):53–9. DOI: 10.1182/blood-2002-12-3842. PMID: 12609836.Spaepen K., Stroobants S., Dupont P. et al. Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high- dose chemotherapy and stem cell transplantation. Blood 2003;102(1):53–9. DOI: 10.1182/blood-2002-12-3842. PMID: 12609836.8.8. Svoboda J., Andreadis C., Elstrom R. et al. Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation. Bone Marrow Transplant 2006;38(3):211–6. DOI: 10.1038/sj.bmt.1705416. PMID: 16770314.Svoboda J., Andreadis C., Elstrom R. et al. Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation. Bone Marrow Transplant 2006;38(3):211–6. DOI: 10.1038/sj.bmt.1705416. PMID: 16770314.9.9. Becherer A., Mitterbauer M., Jaeger U. et al. Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation. Leukemia 2002;16(2): 260–7. DOI: 10.1038/sj.leu.2402342. PMID: 11840293.Becherer A., Mitterbauer M., Jaeger U. et al. Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation. Leukemia 2002;16(2): 260–7. DOI: 10.1038/sj.leu.2402342. PMID: 11840293.10.10. Filmont J.E., Czernin J., Yap C. et al. Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation. Chest 2003;124(2):608–13. PMID: 12907550.Filmont J.E., Czernin J., Yap C. et al. Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation. Chest 2003;124(2):608–13. PMID: 12907550.11.11. Crocchiolo R., Canevari C., Assanelli A. et al. Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation. Leuk Lymphoma 2008;49(4):727–33. DOI: 10.1080/10428190701885545. PMID: 18398740.Crocchiolo R., Canevari C., Assanelli A. et al. Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation. Leuk Lymphoma 2008;49(4):727–33. DOI: 10.1080/10428190701885545. PMID: 18398740.12.12. Sauter C.S., Matasar M.J., Meikle J. et al. Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma. Blood 2015;125(16):2579–81. DOI: 10.1182/blood-2014-10-606939. PMID: 25758829.Sauter C.S., Matasar M.J., Meikle J. et al. Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma. Blood 2015;125(16):2579–81. DOI: 10.1182/blood-2014-10-606939. PMID: 25758829.13.13. Palmer J., Goggins T., Broadwater G. et al. Early post transplant (F-18)2-fluoro-2- deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma. Bone Marrow Transplant 2011;46(6):847–51. DOI: 10.1038/bmt.2010.203. PMID: 20856212.Palmer J., Goggins T., Broadwater G. et al. Early post transplant (F-18)2-fluoro-2- deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma. Bone Marrow Transplant 2011;46(6):847–51. DOI: 10.1038/bmt.2010.203. PMID: 20856212.14.14. Alousi A.M., Saliba R.M., Okoroji G.J. et al. Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation. Br J Haematol 2008;142(5):786–92. DOI: 10.1111/j.1365-2141.2008.07277.x. PMID: 18564354.Alousi A.M., Saliba R.M., Okoroji G.J. et al. Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation. Br J Haematol 2008;142(5):786–92. DOI: 10.1111/j.1365-2141.2008.07277.x. PMID: 18564354.15.15. Bondly C., Johnston P.B., Lowe V. et al. Positive positron emission tomography (PET) pre-autologous stem cell transplant (ASCT) in non-Hodgkin lymphoma (NHL) does not preclude successful outcome. Biol Blood Marrow Transplant 2006; 12(2 Suppl 1):18–9. DOI: 10.1016/j.bbmt.2005.11.060.Bondly C., Johnston P.B., Lowe V. et al. Positive positron emission tomography (PET) pre-autologous stem cell transplant (ASCT) in non-Hodgkin lymphoma (NHL) does not preclude successful outcome. Biol Blood Marrow Transplant 2006; 12(2 Suppl 1):18–9. DOI: 10.1016/j.bbmt.2005.11.060.16.16. Qiao W., Zhao J., Xing Y. et al. Predictive value of [18F]fluoro-2-deoxy-Dglucose positron emission tomography for clinical outcome in patients with relapsed/refractory diffuse large B-cell lymphoma prior to and after autologous stem cell transplant. Leuk Lymphoma 2014;55(2):276–82. DOI: 10.3109/10428194.2013.797974. PMID: 23617323.Qiao W., Zhao J., Xing Y. et al. Predictive value of [18F]fluoro-2-deoxy-Dglucose positron emission tomography for clinical outcome in patients with relapsed/refractory diffuse large B-cell lymphoma prior to and after autologous stem cell transplant. Leuk Lymphoma 2014;55(2):276–82. DOI: 10.3109/10428194.2013.797974. PMID: 23617323.17.17. Swerdlow S.H., Campo E., Harris N.L. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. Lyon: IARC, 2008.Swerdlow S.H., Campo E., Harris N.L. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. Lyon: IARC, 2008.18.18. Cheson B.D., Pfistner B., Juweid M.E. et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25(5):579–86. PMID: 17242396.Cheson B.D., Pfistner B., Juweid M.E. et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25(5):579–86. PMID: 17242396.19.19. Kleinbaum D.G., Klein M. Survival Analysis. A Self-Learning Text. 2nd edn. Springer, 2002. 583 p.Kleinbaum D.G., Klein M. Survival Analysis. A Self-Learning Text. 2nd edn. Springer, 2002. 583 p.